Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
unknown

Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis

NCT06113653
completed

Study of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)

NCT02536625
completed

A Study of Streptococcus Pneumonia Colonisation and Invasive Disease in Cambodian Children

NCT03331952

Clinical Trials (3)

Showing 3 of 3 trials
NCT06113653

Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis

Unknown
NCT02536625

Study of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)

Completed
NCT03331952

A Study of Streptococcus Pneumonia Colonisation and Invasive Disease in Cambodian Children

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3